Paeds Vivas · fetal-neonatal-and-perinatal
Neonatal bacterial infection and sepsis: Viva
Branching clinical structured oral on neonatal bacterial sepsis: risk assessment, clinical evaluation, empiric antibiotic selection, and stewardship decisions.
On this page & tools
Target exams
Branch 1: Risk assessment
The candidate should identify that this infant has multiple risk factors for early-onset sepsis: maternal GBS colonisation, inadequate intrapartum antibiotic prophylaxis (defined as less than 4 hours of antibiotics before delivery), and the presenting signs of temperature instability and poor feeding. This constellation warrants immediate evaluation. [1]
The Neonatal Early-Onset Sepsis Calculator is a validated tool for infants born at 34 weeks gestation or more that integrates maternal risk factors (GBS status, duration of membrane rupture, intrapartum fever, adequacy of intrapartum prophylaxis) with the infant's clinical presentation to estimate the probability of early-onset sepsis. The updated 2024 version uses a contemporary cohort reflecting current epidemiology. [3]
However, this infant is already symptomatic, so the clinical assessment overrides the calculator. Symptomatic infants need full evaluation and empiric antibiotics regardless of the calculated probability. The calculator guides decisions for asymptomatic or equivocally symptomatic infants. [1]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References3Show ledgerHide ledger
- [1]Puopolo KM Management of Neonates Born at >=35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics, 2018.PMID 30455342
- [2]Polin RA Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics, 2012.PMID 22547779
- [3]Kuzniewicz MW Update to the Neonatal Early-Onset Sepsis Calculator Utilizing a Contemporary Cohort. Pediatrics, 2024.PMID 39314183